
CAS 1082744-20-4
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produits concernés.
PF 04447943
CAS :PF 04447943 is a small-molecule, orally bioavailable drug with potential for the treatment of inflammatory bowel disease (IBD). PF 04447943 is a potent inhibitor of TNF-α, which is involved in the pathogenesis of IBD. This compound has been shown to have statistically significant efficacy in wild-type mice and to have low expression in human nuclear DNA. The onset latency of this drug is approximately one week. PF 04447943 inhibits NF-κB and other signal pathways that are involved in the inflammatory response. It also inhibits glutamate dehydrogenase and has shown activity against natural compounds in vitro.
Formule :C20H25N7O2Degré de pureté :Min. 95%Masse moléculaire :395.46 g/molPF-04447943
CAS :PF-04447943, a selective PDE9A inhibitor (IC50=12nM), may aid sickle cell anemia research with its anti-inflammatory properties.Formule :C20H25N7O2Degré de pureté :97.01% - 99.36%Couleur et forme :SolidMasse moléculaire :395.46



